A Missouri judge has approved Bayer’s $7.25 billion settlement of lawsuits alleging that its Roundup weedkiller caused cancer, a major step in a legal fight that has weighed on the company for years. Judge Timothy Boyer of a state court in St Louis ruled on November 20 that the deal was fair and adequate.

Boyer rejected objections that individual payouts would be too low compared with amounts paid to people who settled earlier. He also said that delaying payments could leave victims, including people with terminal cancer, waiting an indefinite number of years.

A broad settlement, with cases left out

Announced in February, the settlement was designed to resolve nearly all current and future Roundup claims in the United States. Bayer had faced about 65,000 claims in state and federal courts from people who said they developed cancer after using the weedkiller at home or at work.

The approval does not settle every case. Some lawsuits pending in federal court are excluded. Bayer says about 200 such cases remain in litigation and that a recent US Supreme Court decision gives it strong defenses.

A changing legal landscape

That ruling came five months before Boyer’s decision. In a 7–2 vote, the Supreme Court overturned a $1.25 million jury award to Missouri resident John Durnell, who had blamed years of exposure to glyphosate, Roundup’s active ingredient, for his non-Hodgkin lymphoma. The court agreed with Bayer that federal pesticide law barred state-law claims alleging a failure to warn.

Christopher Seeger, a lawyer for many of the plaintiffs, said the decision narrowed Roundup victims’ ability to pursue claims in court. He also said he hoped the settlement relief would reach victims as quickly as possible.

Bayer’s position and the road ahead

Bayer has long maintained that Roundup and glyphosate are safe, citing decades of studies that it says found no link between glyphosate and cancer. The approved settlement marks a milestone in the company’s effort to limit the risks of pending and future litigation, its chief executive, Bill Anderson, said.

The company settled much of the Roundup litigation for $10.9 billion in 2020, but did not win court approval for a separate $1.25 billion deal aimed at resolving future claims. Bayer bought Monsanto, which produces Roundup, for $63 billion in 2018; its share price has fallen 46% since the acquisition.